{"id":34436,"date":"2026-01-06T18:19:13","date_gmt":"2026-01-06T17:19:13","guid":{"rendered":"https:\/\/tirzepatyd.eu\/?post_type=product&p=34436"},"modified":"2026-07-16T14:43:34","modified_gmt":"2026-07-16T12:43:34","slug":"retatrutid-20mg","status":"publish","type":"product","link":"https:\/\/tirzepatyd.eu\/cs\/obchod-produkt\/retatrutid-20mg\/","title":{"rendered":"Triple G 20mg mg lahvi\u010dka GLP3"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Triple G GLP3 (Retatrutide 20 mg) \u2013 charakteristika<\/h2>

Triple G GLP3 (Retatrutid 20 mg)<\/strong>, ozna\u010dovan\u00fd tak\u00e9 jako GLP3 reta<\/strong>, Triple G<\/strong> nebo LY3437943<\/strong>, je syntetick\u00fd v\u00fdzkumn\u00fd peptid pat\u0159\u00edc\u00ed do skupiny trojn\u00e1sobn\u00fdch agonist\u016f receptor\u016f GLP-1, GIP a glukagonov\u00e9ho receptoru. Tato slou\u010denina byla vyvinuta jako multireceptorov\u00e1 molekula, kter\u00e1 umo\u017e\u0148uje soub\u011b\u017enou anal\u00fdzu t\u0159\u00ed v\u00fdznamn\u00fdch sign\u00e1ln\u00edch drah pod\u00edlej\u00edc\u00edch se na regulaci metabolismu, gluk\u00f3zov\u00e9 homeost\u00e1zy a energetick\u00e9 bilance.<\/p>

Charakteristick\u00fdm rysem Retatrutid 20 mg<\/strong> je jeho aktivita v\u016f\u010di receptor\u016fm GLP-1R, GIPR a GCGR. Aktivace receptoru GLP-1 je analyzov\u00e1na v kontextu inkretinov\u00e9 signalizace, gluk\u00f3zov\u011b z\u00e1visl\u00e9 inzulinotropn\u00ed odpov\u011bdi, regulace p\u0159\u00edjmu potravy a mechanism\u016f souvisej\u00edc\u00edch s pocitem sytosti. Receptor GIP z\u016fst\u00e1v\u00e1 v\u00fdznamn\u00fdm c\u00edlem v\u00fdzkumu gluk\u00f3zov\u00e9ho metabolismu a metabolick\u00e9 odezvy, zat\u00edmco glukagonov\u00e1 slo\u017eka je analyzov\u00e1na z hlediska energetick\u00fdch p\u0159em\u011bn, mobilizace metabolick\u00fdch substr\u00e1t\u016f a metabolismu lipid\u016f.<\/p>

Viz tak\u00e9 Triple G 20 MG PEN<\/a><\/strong><\/p>

Spojen\u00ed t\u0159\u00ed receptorov\u00fdch profil\u016f v jedn\u00e9 molekule odli\u0161uje GLP3 reta<\/strong> od klasick\u00fdch agonist\u016f GLP-1 a du\u00e1ln\u00edch slou\u010denin, kter\u00e9 p\u016fsob\u00ed sou\u010dasn\u011b na receptory GLP-1 a GIP. Z tohoto d\u016fvodu p\u0159edstavuje retatrutid zaj\u00edmav\u00fd v\u00fdzkumn\u00fd materi\u00e1l v projektech t\u00fdkaj\u00edc\u00edch se modern\u00ed metabolick\u00e9 farmakologie, fyziologie inkretinov\u00fdch receptor\u016f a vztah\u016f mezi signalizac\u00ed GLP-1, GIP a glukagonu.<\/p>

Uveden\u00fd obsah produktu \u010din\u00ed 20 mg retatrutidu<\/strong>, co\u017e umo\u017e\u0148uje vyu\u017eit\u00ed tohoto materi\u00e1lu p\u0159i kvalitativn\u00edch anal\u00fdz\u00e1ch, srovn\u00e1vac\u00edch zkou\u0161k\u00e1ch a referen\u010dn\u00edch postupech prov\u00e1d\u011bn\u00fdch v laboratorn\u00edch podm\u00ednk\u00e1ch. Produkt je ur\u010den v\u00fdhradn\u011b pro v\u011bdeck\u00fd v\u00fdzkum, laboratorn\u00ed anal\u00fdzy a referen\u010dn\u00ed \u00fa\u010dely.<\/p>

Kde koupit a dostupnost p\u0159\u00edpravku Retatrutide 20 mg online<\/h2>

Retatrutid 20 mg<\/strong> V sou\u010dasn\u00e9 dob\u011b nen\u00ed standardn\u011b dostupn\u00fd jako schv\u00e1len\u00fd l\u00e9\u010div\u00fd p\u0159\u00edpravek v l\u00e9k\u00e1rn\u00e1ch. Tato l\u00e1tka je p\u0159edm\u011btem pokro\u010dil\u00fdch klinick\u00fdch studi\u00ed a je i nad\u00e1le zkoum\u00e1na v r\u00e1mci v\u00fdvojov\u00fdch program\u016f zam\u011b\u0159en\u00fdch na multireceptorov\u00e9 agonisty.<\/p>

V internetov\u00e9m prodeji lze narazit na produkty popisovan\u00e9 jako GLP3 reta<\/strong>, Peptid Triple G<\/strong>, Retatrutid 20 mg<\/strong> nebo V\u00fdzkumn\u00fd peptid LY3437943<\/strong>. Produkty tohoto druhu se nab\u00edzej\u00ed jako materi\u00e1ly ur\u010den\u00e9 v\u00fdhradn\u011b pro v\u00fdzkumn\u00e9 \u00fa\u010dely (research use only), ur\u010den\u00e9 k laboratorn\u00edm anal\u00fdz\u00e1m a referen\u010dn\u00edm \u00fa\u010del\u016fm.<\/p>

P\u0159i v\u00fdb\u011bru v\u00fdzkumn\u00e9ho produktu maj\u00ed z\u00e1sadn\u00ed v\u00fdznam informace t\u00fdkaj\u00edc\u00ed se deklarovan\u00e9ho obsahu, \u010distoty materi\u00e1lu, formy produktu, dokumentace kvality a podm\u00ednek skladov\u00e1n\u00ed. Retatrutid, kter\u00fd je online dostupn\u00fd jako v\u00fdzkumn\u00fd reagent, nen\u00ed l\u00e9\u010div\u00fdm p\u0159\u00edpravkem a m\u011bl by b\u00fdt pou\u017e\u00edv\u00e1n v\u00fdhradn\u011b v kontrolovan\u00fdch laboratorn\u00edch podm\u00ednk\u00e1ch.<\/p>

Pod\u00edvejte se tak\u00e9 na GLP-1 (Orforglipron) kapsle 5mg\/60caps<\/a><\/p>

Studie t\u00fdkaj\u00edc\u00ed se p\u0159\u00edpravku Retatrutide 20 mg<\/h2>

Retatrutid vzbudil velk\u00fd z\u00e1jem v\u011bdeck\u00e9 obce d\u00edky sv\u00e9 soub\u011b\u017en\u00e9 aktivit\u011b v\u016f\u010di receptor\u016fm GLP-1, GIP a glukagonu. V publikovan\u00fdch klinick\u00fdch studi\u00edch byl analyzov\u00e1n jeho vliv na t\u011blesnou hmotnost, kontrolu glyk\u00e9mie, t\u011blesn\u00e9 slo\u017een\u00ed a dal\u0161\u00ed parametry souvisej\u00edc\u00ed s metabolismem a energetickou bilanc\u00ed.<\/p>

Ve studii f\u00e1ze 2, jej\u00ed\u017e v\u00fdsledky byly publikov\u00e1ny v \u010dasopise \u201eNew England Journal of Medicine\u201d, byl hodnocen retatrutid u dosp\u011bl\u00fdch osob s obezitou nebo nadv\u00e1hou. B\u011bhem 48t\u00fddenn\u00edho sledov\u00e1n\u00ed byly analyzov\u00e1ny r\u016fzn\u00e9 d\u00e1vky a postupn\u00e9 zvy\u0161ov\u00e1n\u00ed mno\u017estv\u00ed testovan\u00e9 l\u00e1tky. V\u00fdsledky uk\u00e1zaly jasnou souvislost mezi \u00farovn\u00ed expozice a pozorovan\u00fdmi zm\u011bnami t\u011blesn\u00e9 hmotnosti. Ve skupin\u00e1ch, kter\u00e9 dost\u00e1valy nejvy\u0161\u0161\u00ed d\u00e1vky, dos\u00e1hlo pr\u016fm\u011brn\u00e9 sn\u00ed\u017een\u00ed t\u011blesn\u00e9 hmotnosti p\u0159ibli\u017en\u011b 24%, co\u017e pouk\u00e1zalo na v\u011bdeck\u00fd potenci\u00e1l trojit\u00e9 receptorov\u00e9 aktivace.<\/p>

Dal\u0161\u00ed anal\u00fdzy uk\u00e1zaly, \u017ee pozorovan\u00e9 zm\u011bny t\u011blesn\u00e9 hmotnosti prob\u00edhaly postupn\u011b v pr\u016fb\u011bhu studie a na konci 48t\u00fddenn\u00edho sledovac\u00edho obdob\u00ed nedos\u00e1hly z\u0159eteln\u00e9 stabilizace. V publikac\u00edch t\u00fdkaj\u00edc\u00edch se t\u011blesn\u00e9ho slo\u017een\u00ed byly rovn\u011b\u017e analyzov\u00e1ny pom\u011bry zm\u011bn tukov\u00e9 a beztukov\u00e9 t\u011blesn\u00e9 hmotnosti, co\u017e umo\u017enilo \u0161ir\u0161\u00ed posouzen\u00ed vlivu zkouman\u00e9 l\u00e1tky na metabolick\u00e9 procesy.<\/p>

Retatrutid byl tak\u00e9 zkoum\u00e1n u \u00fa\u010dastn\u00edk\u016f s diabetem 2. typu. V t\u011bchto studi\u00edch byly mimo jin\u00e9 hodnoceny zm\u011bny glyk\u00e9mie, hladiny glykovan\u00e9ho hemoglobinu, t\u011blesn\u00e9 hmotnosti a vybran\u00fdch kardiometabolick\u00fdch parametr\u016f. V\u00fdsledky nazna\u010dovaly aktivaci mechanism\u016f charakteristick\u00fdch pro receptory GLP-1 a GIP, dopln\u011bnou o glukagonovou slo\u017eku souvisej\u00edc\u00ed s regulac\u00ed energetick\u00e9ho v\u00fddeje a metabolismu substr\u00e1t\u016f.<\/p>

V odborn\u00e9 literatu\u0159e Triple G GLP3<\/strong> je v sou\u010dasn\u00e9 dob\u011b popisov\u00e1n jako jeden z nejpokro\u010dilej\u0161\u00edch trojn\u00e1sobn\u00fdch receptorov\u00fdch agonist\u016f. D\u00edky rostouc\u00edmu po\u010dtu studi\u00ed p\u0159edstavuje retatrutid cenn\u00fd v\u00fdzkumn\u00fd n\u00e1stroj v projektech zam\u011b\u0159en\u00fdch na inkretinovou signalizaci, metabolismus gluk\u00f3zy, regulaci energetick\u00e9 bilance, metabolismus lipid\u016f a srovn\u00e1n\u00ed jednoduch\u00fdch, dvojit\u00fdch a trojit\u00fdch agonist\u016f.<\/p>

V\u011bdeck\u00e9 zdroje:<\/strong><\/p>

https:\/\/pubmed.ncbi.nlm.nih.gov\/37366315\/<\/a>\"GLP3<\/a><\/p>

https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2301972<\/a><\/p>

https:\/\/pubmed.ncbi.nlm.nih.gov\/37385280\/<\/a><\/p>

https:\/\/pubmed.ncbi.nlm.nih.gov\/38858523\/<\/a><\/p>

https:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMe2307282<\/a><\/p>

V\u00fdrobek je ur\u010den pro v\u011bdeck\u00fd v\u00fdzkum a laboratorn\u00ed anal\u00fdzy. V\u0161echny \u010dl\u00e1nky a informace na t\u011bchto webov\u00fdch str\u00e1nk\u00e1ch slou\u017e\u00ed pouze k informa\u010dn\u00edm a vzd\u011bl\u00e1vac\u00edm \u00fa\u010del\u016fm.<\/strong><\/p><\/div><\/div><\/div><\/div><\/section><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>

\u00a0<\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Triple G 20 mg<\/strong> je syntetick\u00fd v\u00fdzkumn\u00fd peptid pat\u0159\u00edc\u00ed do skupiny receptorov\u00fdch triagonist\u016f. Je navr\u017een tak, aby sou\u010dasn\u011b aktivoval receptory GLP-1, GIP a glukagonu, kter\u00e9 hraj\u00ed kl\u00ed\u010dovou roli v regulaci metabolismu a energetick\u00e9ho metabolismu.<\/p>","protected":false},"featured_media":34437,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_members_access_role":[],"_members_access_error":""},"product_brand":[],"product_cat":[124,109,15],"product_tag":[136],"class_list":["post-34436","product","type-product","status-publish","has-post-thumbnail","product_cat-produkty-w-fiolce","product_cat-triple-g","product_cat-laboratory-research","product_tag-fiolka","first","instock","sale","shipping-taxable","purchasable","product-type-simple"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t